Home › Funds › T. Rowe Price › T. Rowe Price Global Impact Equity Fund
Fund family: T. Rowe Price · Filed by T. Rowe Price International Funds, Inc. (CIK 313212) · SEC series S000070716
Share classes and tickers: TGBLX (C000224811), TGPEX (C000224810)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 834 with, 15 against, 1 abstentions (not counted as with management); 3 items carried no recommendation. Shareholder proposals: 4 FOR, 13 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as T. Rowe Price’s manager page (244,024 ballot items across 112 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | T. Rowe Price | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 91.6% | 725 | 93.7% | 208,710 |
| Backed environmental and social shareholder proposals at US companies | n/a | 6 | 2.6% | 3,333 |
Each ballot item this fund voted is set against the votes of the other T. Rowe Price funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most T. Rowe Price funds on 34 items (4.3% of the 798 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most T. Rowe Price funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Linde Plc | 2025-07-29 | Shareholder A shareholder proposal requesting an annual report regarding the alignment of the Company's direct and indirect lobbying activities with the Company's 2050 climate neutrality ambition. | For | AGAINST — 30 of 30 T. Rowe Price funds | Against | — |
| Intuitive Surgical, Inc. | 2026-04-30 | Election of Directors: Amy L. Ladd, M.D. | Against | FOR — 29 of 29 T. Rowe Price funds | Against | Elected, 99.5% support |
| Intuitive Surgical, Inc. | 2026-04-30 | Election of Directors: Craig H. Barratt, Ph.D. | Against | FOR — 29 of 29 T. Rowe Price funds | Against | Elected, 96.6% support |
| Intuitive Surgical, Inc. | 2026-04-30 | Election of Directors: Gary S. Guthart, Ph.D. | Against | FOR — 29 of 29 T. Rowe Price funds | Against | Elected, 97.4% support |
| Intuitive Surgical, Inc. | 2026-04-30 | Election of Directors: Jami Dover Nachtsheim | Against | FOR — 29 of 29 T. Rowe Price funds | Against | Elected, 98.3% support |
| Intuitive Surgical, Inc. | 2026-04-30 | Election of Directors: Joseph C. Beery | Against | FOR — 29 of 29 T. Rowe Price funds | Against | Elected, 98.7% support |
| Intuitive Surgical, Inc. | 2026-04-30 | Election of Directors: Keith R. Leonard, Jr. | Against | FOR — 29 of 29 T. Rowe Price funds | Against | Elected, 99.5% support |
| Intuitive Surgical, Inc. | 2026-04-30 | Election of Directors: Lewis Chew | Against | FOR — 29 of 29 T. Rowe Price funds | Against | Elected, 99.1% support |
| Intuitive Surgical, Inc. | 2026-04-30 | Election of Directors: Monica P. Reed, M.D. | Against | FOR — 29 of 29 T. Rowe Price funds | Against | Elected, 97.8% support |
| Intuitive Surgical, Inc. | 2026-04-30 | Election of Directors: Sreelakshmi Kolli | Against | FOR — 29 of 29 T. Rowe Price funds | Against | Elected, 98.9% support |
| Monolithic Power Systems, Inc. | 2026-06-11 | Election of Directors: Jeff Zhou | Withhold | FOR — 29 of 29 T. Rowe Price funds | Against | Passed (calculated), 94.0% support |
| Monolithic Power Systems, Inc. | 2026-06-11 | Election of Directors: Victor K. Lee | Withhold | FOR — 29 of 29 T. Rowe Price funds | Against | Passed (calculated), 89.8% support |
| MercadoLibre, Inc. | 2026-06-09 | Election of Directors: Class I Nominees: Alejandro Nicolas Aguzin | Withhold | FOR — 18 of 18 T. Rowe Price funds | Against | Passed (calculated), 98.6% support |
| MercadoLibre, Inc. | 2026-06-09 | Election of Directors: Class I Nominees: Susan Segal | Withhold | FOR — 18 of 18 T. Rowe Price funds | Against | Passed (calculated), 94.2% support |
| Orsted A/S | 2026-04-09 | Reelect Lene Skole (Chair) as Director | Abstain | FOR — 16 of 16 T. Rowe Price funds | Against | — |
| Eli Lilly and Company | 2026-05-04 | Shareholder Shareholder proposal to prepare an annual lobbying report. | For | AGAINST — 37 of 40 T. Rowe Price funds | Against | Not approved, 14.9% support |
| Popular, Inc. | 2026-05-08 | Elect eleven directors to the Board of Directors of the Corporation for a one-year term: Alejandro M. Ballester | Against | FOR — 14 of 14 T. Rowe Price funds | Against | Passed (calculated), 96.0% support |
| Popular, Inc. | 2026-05-08 | Elect eleven directors to the Board of Directors of the Corporation for a one-year term: Alejandro M. Sanchez | Against | FOR — 14 of 14 T. Rowe Price funds | Against | Passed (calculated), 97.9% support |
| Popular, Inc. | 2026-05-08 | Elect eleven directors to the Board of Directors of the Corporation for a one-year term: Bertil E. Chappuis | Against | FOR — 14 of 14 T. Rowe Price funds | Against | Passed (calculated), 97.7% support |
| Popular, Inc. | 2026-05-08 | Elect eleven directors to the Board of Directors of the Corporation for a one-year term: Betty DeVita | Against | FOR — 14 of 14 T. Rowe Price funds | Against | Passed (calculated), 98.6% support |
| Popular, Inc. | 2026-05-08 | Elect eleven directors to the Board of Directors of the Corporation for a one-year term: C. Kim Goodwin | Against | FOR — 14 of 14 T. Rowe Price funds | Against | Passed (calculated), 96.4% support |
| Popular, Inc. | 2026-05-08 | Elect eleven directors to the Board of Directors of the Corporation for a one-year term: Carlos A. Unanue | Against | FOR — 14 of 14 T. Rowe Price funds | Against | Passed (calculated), 96.5% support |
| Popular, Inc. | 2026-05-08 | Elect eleven directors to the Board of Directors of the Corporation for a one-year term: Jose R. Rodriguez | Against | FOR — 14 of 14 T. Rowe Price funds | Against | Passed (calculated), 97.7% support |
| Popular, Inc. | 2026-05-08 | Elect eleven directors to the Board of Directors of the Corporation for a one-year term: Maria Luisa Ferre Rangel | Against | FOR — 14 of 14 T. Rowe Price funds | Against | Passed (calculated), 94.4% support |
| Popular, Inc. | 2026-05-08 | Elect eleven directors to the Board of Directors of the Corporation for a one-year term: Richard L. Carrion | Against | FOR — 14 of 14 T. Rowe Price funds | Against | Passed (calculated), 96.7% support |
| Company | Meeting | Item | This fund | Most T. Rowe Price funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Popular, Inc. | 2026-05-08 | Elect eleven directors to the Board of Directors of the Corporation for a one-year term: Robert Carrady | Against | FOR — 14 of 14 T. Rowe Price funds | Against | Passed (calculated), 98.5% support |
| Badger Meter, Inc. | 2026-04-24 | Election of Directors: Glen E. Tellock | Withhold | FOR — 5 of 5 T. Rowe Price funds | Against | Elected, 97.7% support |
| Badger Meter, Inc. | 2026-04-24 | Election of Directors: Henry F. Brooks | Withhold | FOR — 5 of 5 T. Rowe Price funds | Against | Elected, 99.6% support |
| Badger Meter, Inc. | 2026-04-24 | Election of Directors: James F. Stern | Withhold | FOR — 5 of 5 T. Rowe Price funds | Against | Elected, 99.1% support |
| Badger Meter, Inc. | 2026-04-24 | Election of Directors: James W. McGill | Withhold | FOR — 5 of 5 T. Rowe Price funds | Against | Elected, 98.9% support |
| Badger Meter, Inc. | 2026-04-24 | Election of Directors: Melanie K. Cook | Withhold | FOR — 5 of 5 T. Rowe Price funds | Against | Elected, 99.5% support |
| Badger Meter, Inc. | 2026-04-24 | Election of Directors: Tessa M. Myers | Withhold | FOR — 5 of 5 T. Rowe Price funds | Against | Elected, 99.5% support |
| Badger Meter, Inc. | 2026-04-24 | Election of Directors: Todd A. Adams | Withhold | FOR — 5 of 5 T. Rowe Price funds | Against | Elected, 99.4% support |
| Badger Meter, Inc. | 2026-04-24 | Election of Directors: Xia Liu | Withhold | FOR — 5 of 5 T. Rowe Price funds | Against | Elected, 99.2% support |
Download all 34 differences (CSV)
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 455 | 0 |
| Corporate Governance | 109 | 7 |
| Capital Structure | 90 | 0 |
| Compensation | 78 | 0 |
| Audit-related | 65 | 0 |
| Say-on-Pay | 39 | 0 |
| Other Social Issues | 8 | 4 |
| Environment or Climate | 5 | 4 |
| Other | 4 | 0 |
| Extraordinary Transactions | 2 | 0 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Broadcom Inc. | April 20, 2026 | $937,854 | 10 | 0 |
| Deere & Company | February 25, 2026 | $767,796 | 15 | 3 |
| Thermo Fisher Scientific Inc. | May 20, 2026 | $745,036 | 13 | 0 |
| Danaher Corporation | May 5, 2026 | $643,618 | 14 | 0 |
| Gilead Sciences, Inc. | April 30, 2026 | $620,381 | 15 | 3 |
| Natera, Inc. | June 11, 2026 | $608,693 | 8 | 0 |
| Aflac Incorporated | May 4, 2026 | $584,941 | 14 | 1 |
| Eli Lilly and Company | May 4, 2026 | $571,986 | 10 | 2 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| February 25, 2026 | Deere & Company | Shareholder proposal on a report on the return on investment of emission reduction goals Shareholder proposal | Against | For |
| February 25, 2026 | Deere & Company | Shareholder proposal on shareholder right to act by written consent Shareholder proposal | Against | For |
| April 30, 2026 | Gilead Sciences, Inc. | To vote on a stockholder proposal requesting an independent Board Chair policy, if properly presented at the Annual Meeting. Shareholder proposal | Against | For |
| April 30, 2026 | Gilead Sciences, Inc. | To vote on a stockholder proposal requesting a report on the impact of extended patent exclusivities on patient access, if properly presented at the Annual Meeting. Shareholder proposal | Against | For |
| May 4, 2026 | Aflac Incorporated | Independent Board Chairman Shareholder proposal | Against | For |
| May 4, 2026 | Eli Lilly and Company | Shareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. Shareholder proposal | Against | For |
| May 4, 2026 | Eli Lilly and Company | Shareholder proposal to prepare an annual lobbying report. Shareholder proposal | For | Against |
| June 1, 2026 | UnitedHealth Group Incorporated | If properly presented at the 2026 Annual Meeting of Shareholders, the shareholder proposal requesting the adoption of a policy to require any Board Chair to be independent. Shareholder proposal | Against | For |
| April 16, 2026 | Synopsys, Inc. | To vote on a stockholder proposal regarding 'stockholders' right to act by written consent, if properly presented at the meeting. Shareholder proposal | Against | For |
| January 22, 2026 | Intuit Inc. | Shareholder proposal requesting the Board to issue a report on the return on investment of the Company's diversity and inclusion programs Shareholder proposal | Against | For |
| June 15, 2026 | HubSpot, Inc. | A stockholder proposal to change the Company's Sixth Amended and Restated Bylaws to allow 10% holders of the Company's stock the ability to call a special meeting; and Shareholder proposal | For | Against |
| June 16, 2026 | Shopify Inc. | Adopt a Policy on Responsible Use of Artificial Intelligence ("AI") in the Company's Business and Operations Shareholder proposal | Against | For |
856 ballot items at 77 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, T. Rowe Price Global Impact Equity Fund (TGBLX) voted at 77 shareholder meetings of 70 companies, on 856 ballot items in all. Where management made a recommendation, the fund followed it on 98.1% of the items and voted against it 15 times. Its most frequent area of disagreement was corporate governance (7 of its votes against management). It voted on 17 shareholder proposals. It voted FOR the board's own proposals less often than T. Rowe Price's funds as a whole (91.6% against 93.7%). It voted differently from most T. Rowe Price funds on 34 items.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of T. Rowe Price’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.